Pear Therapeutics’ reSET-O prescription digital therapeutic for opioid use disorder lowered healthcare costs and added quality life years post-treatment, according to a Pear-funded analysis published in the Journal of Market Access & Health Policy.
TOP-LINE DATA
Over 12 weeks, using reSET-O in addition to treatment as usual lowered costs by $1,014 and added 0.003 quality-adjusted life years...
A recent study published in the Journal of Medical Internet Research (JMIR) shows initial support for a new version of Woebot – a text-based chatbot app designed to address mental health issues – that is designed to reduce substance use and other measures tied to substance use disorder (SUD).
Conducted by researchers from Stanford University School of Medicine and Woebot Health, the investigation...
The alarming scale of the opioid use disorder (OUD) epidemic has resulted in unprecedented human and economic devastation, and there is significant opportunity for digital tools to alter the gold standard of care to one that is ongoing and on-demand.
The epidemic has only worsened since the onset of COVID-19, given heightened economic instability, social isolation, disruption to transportation...
Digital primary care company Curai Health scored $27.5 million in Series B funding from Morningside Ventures, as well as returning backers General Catalyst and Khosla Ventures. The company, which was founded by Neal Khosla and Xavier Amatriain, runs on a subscription-based model.
Users can pay $7.99 a month for the subscription and then access telemedicine visits with doctors. The service also...
Lucid Lane, a Los Altos, California-based telehealth provider specializing in medication dependence and substance use disorders, has raised $4 million in seed funding. Battery Ventures led the investment.
WHAT THEY DO
Lucid Lane's patient-facing approach combines regular virtual coaching from licensed therapists and data-driven treatment planning. These sessions are conducted as either one-on-one...
About the author: Melissa Jankowski is the executive director of The Non-Emergency Medical Transportation Accreditation Commission (NEMTAC), a non-profit organization dedicated to ensuring safe medical transportation. NEMTAC partners with medical transport brokers and associations to develop best practices and has a role in the establishment of American National Standards that affect the industry...
Boston-based addiction recovery platform DynamiCare Health has collected $4.1 million in seed funding from Hyperplane Venture Capital, former US Representative Patrick J. Kennedy and other unnamed investors.
What they do
Founded in 2016, DynamiCare Health has built a platform supports users’ substance use disorder recovery with a number of smartphone-based features. These include random breath...
This morning San Francisco-based telemedicine platform HeyDoctor announced that its customers will now be able to receive naloxone, including Narcan, through its website and mobile app.
Users will first go through a text chat-based consultation with a physician on HeyDoctor about how and when to use the medication, which can reverse the effects of an opioid overdose. The prescription can then be...
reSET — a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA — is now commercially available for clinicians to prescribe to their patients, according to a release from Pear Therapeutics and Sandoz, a division of Novartis with which Pear partnered back in April.
But while physical prescription drugs are usually handled through a pharmacy, the process...
In one of the few and far between bipartisan bills to be passed during this administration, President Donald Trump signed into law yesterday a new package aimed to help tackle the opioid epidemic, called the Support for Patients and Communities Act.
The latest legislation expands opioid-specific telemedicine services, exempting the technology from certain requirements. It also modifies the...
